ClinicalTrials.gov
ClinicalTrials.gov Menu

Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00137826
Recruitment Status : Completed
First Posted : August 30, 2005
Last Update Posted : December 26, 2011
Sponsor:
Collaborators:
Massachusetts General Hospital
University of Chicago
Information provided by (Responsible Party):
Pasi A. Janne, MD, PhD, Dana-Farber Cancer Institute